Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Board Review
CME
Careers
Cases
Conferences
Videos
Webinars
Podcast Network
Advertising
Buyer's Guide
Vendors
Minnies
RPT Tracker
SNMMI 2026: Page 2
SNMMI inducts six new fellows at 2026 annual meeting
By
AuntMinnie.com staff writers
The SNMMI named six new fellows during its annual meeting in Los Angeles.
June 1, 2026
SNMMI names Richard Carson recipient of 2026 Aebersold Award
By
AuntMinnie.com staff writers
The SNMMI has awarded the Aebersold Award to Richard Carson, PhD, from Yale University.
June 1, 2026
SNMMI: PET tracer that detects deep vein thrombosis wins Image of the Year
By
Will Morton
F-18 GP1 is derived from elarofiban and selectively binds to glycoprotein IIb/IIIa receptors on activated platelets.
June 1, 2026
SNMMI: Novel radiotracer effectively images overactive adrenal glands
By
Liz Carey
University of Michigan researchers report on first-in-human study of SOAT1-targeted nevanimibe C-11.
June 1, 2026
SNMMI: Mouaz Al-Mallah discusses cardiac PET
By
Will Morton
In this interview, Mouaz Al-Mallah, MD, discusses cardiac PET imaging, including new efforts to create more access for patients and the impact of new radiotracers.
June 1, 2026
SNMMI: Point-of-care PET system may guide interventional procedures
By
Amerigo Allegretto
A portable, point-of-care PET system showed success in imaging organs and may be helpful in interventional guidance.
June 1, 2026
Additional Coverage
2024
SNMMI: Brain-dedicated PET scanner cuts claustrophobia, boosts comfort
By
Kate Madden Yee
The findings "support the use of brain-dedicated PET scanners as a patient-centered alternative," researchers wrote.
June 1, 2026
SNMMI: PET tracer detects CTE tau pathology in living patients
By
Kate Madden Yee
Study findings suggest "a clinical role for PET in traumatic brain injury and sports- and military-related neurodegeneration."
May 31, 2026
SNMMI: SPECT/CT tracer shows promise in interstitial lung disease
By
Will Morton
Differentiating between fibrotic scarring and inflammation stages of disease is critical so that physicians can determine what treatment is best for the patient.
May 31, 2026
SNMMI: Alpha-emitting tracer offers neuroendocrine tumor treatment option
By
Kate Madden Yee
An alpha-emitting radiotracer produced remission in patients who had exhausted typical treatment options for neuroendocrine tumors.
May 31, 2026
SNMMI: PET tracer detects both cardiac Inflammation and tumor activity
By
Will Morton
CCR2 is expressed in both atherosclerotic plaques and tumors.
May 31, 2026
SNMMI: Prostate cancer vaccines may improve response to Pluvicto
By
Will Morton
Immunological priming before radiopharmaceutical therapy may enhance clinical efficacy without impairing prostate antigen-specific T-cell response.
May 31, 2026
Previous Page
Page 2 of 3
Next Page